Phototherapeutic Keratectomy for Epithelial Irregular Astigmatism: An Emphasis on Map-Dot-Fingerprint Degeneration

Transepithelial phototherapeutic keratectomy for treatment-resistant recurrent corneal erosion syndrome

BACKGROUND

To evaluate the efficacy and safety of trans-epithelial phototherapeutic keratectomy (TE-PTK) as a treatment for recurrent corneal erosion syndrome (RCES) in patients with symptoms refractory to conventional treatments.

METHODS

All patients who received TE-PTK treatment for RCES had failed 3 or more conventional treatments and were reviewed, and if met criteria, approved by healthcare workers of the British Columbia public health authority (Medical Services Plan (MSP). A retrospective chart review and telephone survey were conducted at the Pacific Laser Eye Centre (PLEC). Exclusion criteria were ocular co-morbidities potentially affecting treatment efficacy.

RESULTS

This study included 593 eyes of 555 patients (46.2% male; 50.9 ± 14.2 years old) who underwent TE-PTK. The leading identified causes of RCES were trauma (45.7%) and anterior basement membrane dystrophy (44.2%). The most common pre-PTK interventions were ocular lubricants (90.9%), hypertonic solutions (77.9%), and bandage contact lenses (50.9%). Thirty-six eyes had undergone surgical interventions such as stromal puncture, epithelial debridement, or diamond burr polishing. Post-PTK, 78% of patients did not require any subsequent therapies and 20% required ongoing drops. Six patients (1.1%) reported no symptom improvement and required repeat TE-PTK for ongoing RCES symptoms after initial TE-PTK. All 6 eyes were successfully retreated with TE-PTK (average time to retreatment was 11.3 ± 14.9 months). There was no significant difference in best corrected visual acuity pre- vs. post-operatively. The mean post-operative follow-up was 60.5 months (range: 5-127 months).

CONCLUSION

TE-PTK has a good efficacy and safety profile for treatment-resistant RCES. The third-party public health-reviewed nature of this study, the low recurrence rate of RCES, and the low PTK retreatment rate suggest that TE-PTK might be considered for wider use in the management of RCES.

IC3D Classification of Corneal Dystrophies-Edition 3

PURPOSE

The International Committee for the Classification of Corneal Dystrophies (IC3D) was created in 2005 to develop a new classification system integrating current information on phenotype, histopathology, and genetic analysis. This update is the third edition of the IC3D nomenclature.

METHODS

Peer-reviewed publications from 2014 to 2023 were evaluated. The new information was used to update the anatomic classification and each of the 22 standardized templates including the level of evidence for being a corneal dystrophy [from category 1 (most evidence) to category 4 (least evidence)].

RESULTS

Epithelial recurrent erosion dystrophies now include epithelial recurrent erosion dystrophy, category 1 ( COL17A1 mutations, chromosome 10). Signs and symptoms are similar to Franceschetti corneal dystrophy, dystrophia Smolandiensis, and dystrophia Helsinglandica, category 4. Lisch epithelial corneal dystrophy, previously reported as X-linked, has been discovered to be autosomal dominant ( MCOLN1 mutations, chromosome 19). Classic lattice corneal dystrophy (LCD) results from TGFBI R124C mutation. The LCD variant group has over 80 dystrophies with non-R124C TGFBI mutations, amyloid deposition, and often similar phenotypes to classic LCD. We propose a new nomenclature for specific LCD pathogenic variants by appending the mutation using 1-letter amino acid abbreviations to LCD. Pre-Descemet corneal dystrophies include category 1, autosomal dominant, punctiform and polychromatic pre-Descemet corneal dystrophy (PPPCD) ( PRDX3 mutations, chromosome 10). Typically asymptomatic, it can be distinguished phenotypically from pre-Descemet corneal dystrophy, category 4. We include a corneal dystrophy management table.

CONCLUSIONS

The IC3D third edition provides a current summary of corneal dystrophy information. The article is available online at https://corneasociety.org/publications/ic3d .

[Phototherapeutic keratectomy for epithelial basement membrane dystrophy : Impact of excimer laser systems used on the changes of visual acuity, refraction and astigmatism]

BACKGROUND

Excimer laser-assisted phototherapeutic keratectomy (PTK) has become established as the gold standard in treatment of epithelial basement membrane dystrophy (EBMD), commonly also known as map-dot-fingerprint dystrophy (MDF). At the Department of Ophthalmology, Saarland University Medical Center in Homburg/Saar, systems from Zeiss Meditec and Schwind have been used. The outcomes of both were compared in this study.

PATIENTS AND METHODS

The retrospective study included patients who underwent PTK with a diagnosis of MDF between 2007 and 2017. A total of 170 operations were performed using Zeiss Meditec MEL-70 (Carl Zeiss Meditec AG, Jena, Germany) and 98 using a Schwind eye-tech-solutions Amaris 750S laser (Schwind eye-tech-solutions GmbH, Kleinostheim, Germany). Preoperative and postoperative data for visual acuity, refraction and astigmatism as well as curvature data from the Pentacam and endothelial cell count were collected. The follow-up period averaged 8 months.

RESULTS

In both groups visual acuity postoperatively was significantly better (Zeiss: p < 0.001, Schwind p < 0.004). The improvement in the Schwind group was less than in the Zeiss group, which is the reason why there was a significant difference between the laser systems postoperatively (p < 0.017). There were no significant changes regarding the spherical equivalent after PTK. Regarding astigmatism, there was a significant decrease in the Zeiss group (p < 0.042), while it did not change significantly in patients treated with Schwind laser (p < 0.217). Overall, this led to a significant postoperative difference between both laser systems (p < 0.014).

CONCLUSION

The PTK can be recommended as an effective treatment method for patients with EBMD, regardless of the laser systems used. Patients benefit from long relief from recurrences with improved or constant visual acuity and stable refraction.

Peripheral hypertrophic subepithelial corneal degeneration: characterization, treatment and association with human leucocyte antigen genes

PURPOSE

To evaluate the efficacy of keratectomy in treating irregular astigmatism caused by peripheral hypertrophic subepithelial corneal degeneration (PHSD) and to study the possible underlying immunological risk factors.

MATERIALS AND METHODS

Patients (14 eyes) with diagnosed PHSD were treated with superficial keratectomy with or without the assistance of phototherapeutic keratectomy (VisX S4; VisX Inc., Santa Ana, CA, USA). Thirteen patients were subjected to analysis of human leucocyte antigen (HLA) genes, complement C4 gene numbers and total plasma immunoglobulin levels. Immunological risk factors between patients and a control group comprising 150 individuals were compared.

RESULTS

The mean preoperative best spectacle corrected visual acuity (BCVA) improved from 0.16 ± 0.22 (LogMAR scale range 0-0.7) to 0.06 ± 0.13 (-0.1-0.4) (p < 0.01). The mean preoperative astigmatism decreased significantly from 3.8 ± 2.1 D (range 1.2-8.2) to 2.1 ± 1.4 (range 0.6-5.0, p = 0.02) based on corneal topography. The HLA-B*44 allele and the ancestral haplotype (AH) 8.1 were found significantly more often in PHSD patients than in controls (both p = 0.03). No differences in the C4 genes were found.

CONCLUSIONS

Astigmatism secondary to PHSD can be effectively treated with keratectomy. Peeling of the fibrotic tissue reduced astigmatism and improved visual performance. We suggest that HLA-B*44 allele and AH 8.1 haplotype are immunological factors predisposing to the development of PHSD. The consequent disruption/alteration of the limbal barrier may lead to corneal peripheral fibrous formation inducing astigmatism.

Long-term follow-up of photorefractive keratectomy for myopia: Comparative study of excimer lasers

PURPOSE

To compare the long-term results of photorefractive keratectomy (PRK) for low to moderate myopia performed using a broad-beam laser system or a scanning-slit laser system.

SETTING

Department of Ophthalmology, University of Helsinki, Helsinki, Finland.

DESIGN

Case-control study.

METHODS

This follow-up study comprised eyes with myopia (-1.25 to -7.00 diopters [D]) or myopic astigmatism (astigmatism lower than -2.50 D) corrected by PRK using a broad-beam (Visx) or scanning-slit (Nidek) laser. Follow-up included a visit at 3 months and at more than 8 years. The uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and manifest refraction were recorded.

RESULTS

The broad-beam group comprised 27 eyes and the scanning-slit group, 34 eyes. At the last postoperative follow-up, the UDVA was 0.0 or better in 55% of eyes in the broad-beam group and 65% of eyes in the scanning-slit group. The CDVA was 0.0 or better in all eyes in the broad-beam group and 96% of eyes in the scanning-slit group. Regarding predictability, 48% and 73% of the eyes, respectively, were within ±0.50 D of the intended spherical equivalent refraction. There were no statistically significant differences between the 2 laser groups in any preoperative or postoperative parameter.

CONCLUSION

There were no significant differences in UDVA, CDVA, or SE after PRK for low to moderate myopia between the broad-beam laser system and the scanning-slit laser system.

FINANCIAL DISCLOSURE

No author has a financial or proprietary interest in any material or method mentioned.

Dystrophia Helsinglandica--corneal morphology, topography and sensitivity in a hereditary corneal disease with recurrent erosive episodes

PURPOSE

The aim of this study was to describe the morphology, corneal topography and sensitivity in individuals with Dystrophia Helsinglandica. This autosomal dominant corneal disease is characterized by recurrent corneal erosive episodes and progressive subepithelial fibrosis not significantly affecting visual acuity.

METHODS

The corneas of nine affected and nine unaffected individuals were examined using slit-lamp biomicroscopy, in vivo confocal microscopy (IVCM) and videokeratography. Corneal mechanical sensitivity was also measured using a non-contact esthesiometer.

RESULTS

Slit-lamp biomicroscopy revealed that the affected individuals represented different stages of corneal changes, from a nearly normal cornea to subepithelial fibrosis of the central cornea. Corneal changes in affected individuals did not significantly decrease the best spectacle-corrected visual acuity. In vivo confocal microscopy detected morphological changes in the epithelium and stroma. Subepithelial opacity formation including altered keratocytes could be found in the anterior stroma in all affected eyes. With the exception of two eyes (one affected and one unaffected), all videokeratographies showed irregular astigmatism. Corneal sensitivity was significantly lower in affected individuals (p = 0.01). Age and corneal sensitivity showed no correlation.

CONCLUSION

The main morphological findings in affected individuals were discrete and progressive subepithelial fibrosis, in the in vivo confocal microscope corresponding to optically dense extracellular matrix and activated keratocytes. Subbasal nerve morphology was changed in the affected family members who also showed a decreased corneal sensitivity. The findings are per se not specific to the disease. The changes probably reflect a healing response to erosive events on the corneal surface influenced by the genotype.

Recurrent Corneal Erosion Syndrome: A Study of 364 Episodes

The purpose of the study was to investigate the management of recurrent corneal erosion syndrome (RES). A retrospective case series design was employed in which all RES cases presenting to the Duke University Eye Center from 1995 to 2002 were included. In total, 364 episodes of RES occurred in 261 patients during the study period. Of this 61% of patients were female (P < .001), average age was 46.0 years, and etiologies included trauma (51.3%), anterior basement membrane dystrophy (29.1%), other etiologies (10.3%) and unknown (9.2%). Treatments included conservative therapy (83.2%), anterior stromal puncture (ASP)(12.6%) and phototherapeutic keratectomy (PTK)(4.1%). Recurrence by treatment was 31.0% for conservative therapy, 23.9% for ASP and 26.7% for PTK. Subjects treated with ASP and PTK had failed prior treatment efforts. Conclusions include that RES was commonly associated with trauma and the female gender, and that one-third of conservatively treated episodes and one-quarter of surgically treated episodes (ASP or PTK) recurred.